Welcome, visitor! [ Register | Login rss Google+ facebook twitter LinkedIn Pinterest FeedBurner

National Institutes for Quantum and Radiological Science and Technology (QST)


  • Company Name: National Institutes for Quantum and Radiological Science and Technology
  • State/Prefecture: Chiba Prefecture
  • City/Town/Village: Inage-Ku, Chiba City
  • Street: 4-9-1 Anagawa
  • Country: Japan
  • Zip/Postal Code: 263-8555
  • Phone: +81-(0)43-206-3025
  • Website: http://www.nirs.qst.go.jp/ENG/
  • Contact: kokusai@qst.go.jp
  • Listed: 09/03/2018 11:50 am
  • Expires: 343 days, 12 hours
National Institutes for Quantum and Radiological Science and Technology (QST)
 

The National Institutes for Quantum and Radiological Science and Technology (QST) established in 2016, was newly launched as a National Research and Development Agency in Chiba, Japan. QST combines the research and development abilities of five Japanese national institutes in the fields of radiology, quantum beams and nuclear fusion to form a world-class institution in quantum science and technology research.

Among these institutes, National Institute of Radiological Sciences (NIRS) is a world-leading radiological research institute with outstanding research levels and facilities, and it is mainly engaged in R&D into innovative medical use of radiation and research into the impact of radiation and radiation medicine. NIRS was established in 1957 as the Japan’s only one institute of radiology, has been driving force for the advancement of radiation science in decades. It is headed by President Toshio Hirano.

How to watch YouTube video with translated caption

Ad Reference ID: 4595b8d81df3a2fb

No Tags

  

One Related article of “National Institutes for Quantum and Radiological Science and Technology (QST)”

  1. Japanese Medical Research Institute and Pharmaceutical Company Collaborate to Develop New Drug for Alzheimer’s Disease
    Date: Aug 29, 2018

    KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by KinoPharma, to prevent the accumulation of protein called tau (hereafter “tau protein”) (*1), which is considered a cause of Alzheimer’s disease (AD). The National Institutes’ research group is led by MD & PhD Makoto Higuchi from the Department of Functional Brain Imaging Research of the National Institute of Radiological Sciences (NIRS).

    Continue reading »

Leave a Reply

You must be logged in to post a comment.

To inquire about this ad listing, complete the form below to send a message to the ad poster.

Group Site

  • Ad 1
  • Ad 2
  • Ad 3
  • Ad 4